Authors


Betsy Adegborioye

Latest:

Practice Update: Treating Patients Hospitalized With COVID-19

Several institutions have published guidance on how to treat patients hospitalized with COVID-19.


Justine Magalona, PharmD candidate

Latest:

Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.


Russell Libby, MD

Latest:

Detecting Crossover Symptoms of COVID-19, Influenza

As respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.


Total Pharmacy Team

Latest:

The Health Care Professional’s Role in Creating Equitable Patient Outcomes

An essay by Lord Simon Woolley that was published in BMJ calls on the medical community to speak up on how failed drug laws disproportionately harm black communities.


Bernard A. Cohen, MD

Latest:

Current and Future Treatments for Hidradenitis Suppurativa

Hidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.


Staff Writer

Latest:

Pilot Program From Custom Health, L.A. Care, Tackles Medication Adherence

Custom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.


Jeff Puetz, Director, Field Business Coaching, Good Neighbor Pharmacy

Latest:

Using Data to Put a Stop to Your Pharmacy's Profit Leakage

Technology will help you identify potential reimbursement problems before they trigger reduced payments or claims audits.


John Parkinson

Latest:

Tecovirimat Predicted to Reduce Mpox Symptom Duration by 6 Days

The use of tecovirimat for monkeypox and other non-variola orthopoxvirus infections is under an expanded access IND protocol, according to the CDC.


Tom Knight, CEO, Invistics

Latest:

Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget Cuts

With the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.


Kristen Crossley, MA

Latest:

Chewable Tablet Receives FDA Approval for Internal and External Parasites in Dogs

Afoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.


Todd D. Sorensen, PharmD

Latest:

A Partnership to Optimize Medication Use and Patient Outcomes

Initiative promotes adoption of value-based care models in community pharmacy settings.


Rachel Krishewsky, BS, BPS, PharmD candidate

Latest:

COVID-19 Vaccines: A Focus on Safety

Ease patients’ concerns by being well versed in the safety profiles of each vaccine.


Formulary Watch Staff

Latest:

FDA: PDUFA Date Assigned for Arexvy as RSV Prevention in Age 50 to 59

June 7, 2024 is the target PDUFA date for the additional indication of GSK's respiratory syncytial virus vaccine Arexvy.


Dermatology Times Staff

Latest:

Guselkumab Phase 3 Data Show Sustained Skin Clearance After 5 Years

Tremfya phase 3 data shows skin clearance rates were maintained at 5 years with 55.5% of patients achieving an IGA score of 0% and 53% achieving PASI 100 response in VOYAGE 2 trial.


Esther H. Kanner, PharmD Candidate 2023

Latest:

Vitamin D and COVID-19: An Evidence-Based Review

In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.


Brielle Benyon

Latest:

Recapping the FDA's Cancer Drug Approvals From The Winter

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.


Beth Plumptre

Latest:

Is ChatGPT Health Care’s Next Big Thing?

Artificial intelligence has many applications in health care, but hurdles to widespread adoption remain.


Andrew L. Wilson, PharmD, FASHP

Latest:

Transparency in Drug Pricing Can Start With 340B

There are 3 key considerations in understanding 340B program results and benefits.


Anna Legreid Dopp, PharmD, CPHQ

Latest:

The Pharmacist’s Role Beyond COVID-19

Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.


Heidi Anne Duerr, MPH

Latest:

What's Driving the Increasing Number of Adult Women With ADHD?

More and more women are being diagnosed with ADHD in adulthood. What's behind this increase?



Kelly McGrail-Pokuta

Latest:

Lowering Patient Drug Costs with Biosimilars Can Happen When the Right Teams Come Together

Pharmacy benefit managers can help health plans understand when to best leverage and align to biosimilars and other cost-effective treatments.


Thomas C. Blevins, MD, ECNU, FACE, FNLA

Latest:

Basal Insulin Therapies for Diabetes Management

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Thomas C. Blevins, MD, ECNU, FACE, FNLA, review FDA-approved basal insulins for the management of diabetes.


Shreya Doshi, MBBS

Latest:

Health Care Workers Can be Part of the Climate Change Solution

Anesthetic gases and meter dose inhalers, how we use our antibiotics, how we use our resources for infection prevention and control, and how we use plastic and food in our hospitals all add up.


Razwan Miah, BPS, PharmD

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Mike Johnston, CPhT-Adv

Latest:

From Stagnation to Success: Traits That Set Successful Pharmacy Technicians Apart

Pharmacy technicians who prioritize learning, networking, and persistence can become incredibly successful in their chosen career.


Jonathan Ogurchak, PharmD, CSP

Latest:

Practice Update: Treating Patients Hospitalized With COVID-19

Several institutions have published guidance on how to treat patients hospitalized with COVID-19.


Megan M. Pantos, PharmD

Latest:

Finerenone for Heart Failure and Kidney Disease Associated With Type 2 Diabetes

The FDA has approved finerenone (Kerendia, Bayer) for the treatment of adults with chronic kidney disease (CKD) associated with type 2 diabetes.


Tiana Tran, PharmD

Latest:

FDA Approves Olipudase Alfa-rpcp for Acid Sphingomyelinase Deficiency

Acid sphingomyelinase deficiency is a rare, progressive genetic disease associated with significant morbidity and mortality.


Michelle Hill, CPhT

Latest:

The Four Attributes of a Lead Pharmacy Technician

There are some crucial differences between a good pharmacy technician and great lead technician.

© 2024 MJH Life Sciences

All rights reserved.